Abstract
Although there have been advances in the management of unstable angina/non-ST segment elevation myocardial infarction syndromes, the rate of cardiovascular mortality after discharge is still unacceptably high. With many therapeutic options available, the clinician is challenged to identify the safest and most effective treatment for long term survival of each individual patient